NCT02183441 Bioavailability of BI 1356 After Co-administration With Ritonavir Compared to the Bioavailability of BI 1356 Alone in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02183428 Bioavailability of BI 1356 and Glyburide in Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT02183415 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS as Tablet in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT02183402 Pharmacokinetics, Safety and Tolerability of Digoxin With or Without Co-administration of BI 1356 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02183389 Bioavailability of Warfarin After Coadministration With Multiple Doses of BI 1356 Compared to the Bioavailability of Warfarin Alone in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02183376 Pharmacokinetics and Pharmacodynamics of BI 1356 in Subjects With Different Degrees of Liver Impairment as Compared to Healthy Subjects Status COMPLETED Phase PHASE1
NCT02183363 Bioavailability of BI 1356 After Single Oral Administration Given as Different Tablet Formulation in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02183350 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT02183337 Bioavailability of BI 1356 With and Without Co-administration of Pioglitazone and the Bioavailability of Pioglitazone With and Without Coadministration of BI 1356 in Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT02183324 BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT02183311 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising Oral Doses and Multiple Rising Oral Doses of BI 1356 BS in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02183298 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 1356 BS in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02183285 Tolerability of Pharmaton PHL 00747 in Healthy, Young Female Subjects of Child-bearing Potential Status COMPLETED Phase PHASE3
NCT02183259 Bioavailability, Pharmacokinetics and Safety of ESR 1150 CL in Healthy Adult Male Volunteers Status COMPLETED Phase PHASE1
NCT02183246 Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients Status TERMINATED Phase PHASE3
NCT02183233 Efficacy and Safety of Eschscholtzia Californica in Treating Primary Insomnia Status TERMINATED Phase PHASE3
NCT02183220 Efficacy and Tolerability of Metamizol in Patients With Episodic Moderate Headache Status COMPLETED Phase PHASE3
NCT02183181 Bioequivalence Study of Meloxicam Capsules 15 mg (Mobic® Capsules 15 mg) Versus Meloxicam Tablets 15 mg (Mobic® Tablets 15 mg) in Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT02183168 Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT02183155 Effect of Meloxicam Tablets on Bleeding Time in Healthy Subjects Status COMPLETED Phase PHASE4